肾功能和疾病规范命名：改善全球肾脏病预后（KDIGO）会议共识
收稿日期: 2022-01-20
网络出版日期: 2022-08-09
基金资助
江苏省儿科医学创新团队项目(CXTDA2017022);江苏省自然科学基金青年基金项目(BK201 90251)
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
为规范描述肾功能和疾病的专业术语,2019年6月改善全球肾脏病预后组织（KDIGO）召开共识会议,对肾脏功能和疾病、肾衰竭、急性肾脏病和急性肾损伤、慢性肾脏病及肾脏评估共5个部分的内容制定了相应的术语表,并就以下建议达成共识。①对于肾脏功能和疾病的一般描述,使用术语“kidney”,而不使用“renal”或前缀“nephro-”;②使用“肾衰竭（kidney failure）”并适当描述是否存在相应症状、体征和治疗,而不是“终末期肾脏疾病（end-stage kidney disease）”;③使用KDIGO对急性肾脏病（AKD）和急性肾损伤（AKI）进行定义和分类;④使用KDIGO对慢性肾脏病（CKD）进行定义和分类;⑤使用特定的肾脏检测指标,例如蛋白尿或肾小球滤过率（GFR）降低,而不是肾功能“异常（abnormal）”或“降低（reduced）”来描述肾脏结构和功能的改变。文章简要总结会议的主要讨论。
王忍 , 高春林 , 夏正坤 , 张沛 译 . 肾功能和疾病规范命名：改善全球肾脏病预后（KDIGO）会议共识[J]. 临床儿科杂志, 2022 , 40(8) : 627 -633 . DOI: 10.12372/jcp.2022.22e0124
| [1] | Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States[J]. Am J Kidney Dis, 2019, 73(3 Suppl 1): A7-A8. |
| [2] | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. |
| [3] | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736-1788. |
| [4] | Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference[J]. Kidney Int, 2020, 97(6): 1117-1129. |
| [5] | Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference[J]. Nephrology (Carlton), 2020, 25(8): 589-598. |
| [6] | Lameire N, Kellum JA. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2)[J]. Crit Care, 2013, 17(1): 205. |
| [7] | Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)[J]. Crit Care, 2013, 17(1): 204. |
| [8] | Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med, 2013, 158(11): 825-830. |
| [9] | Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference[J]. Kidney Int, 2020, 98(2): 294-309. |
| [10] | Davison SN, Levin A, Moss AH, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care[J]. Kidney Int, 2015, 88(3): 447-459. |
| [11] | James MT, Levey AS, Tonelli M, et al. Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a universal health care system[J]. JAMA Netw Open, 2019, 2(4): e191795. |
| [12] | Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup[J]. Nat Rev Nephrol, 2017, 13(4): 241-257. |
| [13] | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266. |
/
| 〈 |
|
〉 |
沪公网安备 31011002000392号
